- Home
- SHOO vs OLMA Comparison
SHOO vs OLMA Comparison
Compare SHOO & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SHOO | OLMA |
|---|---|---|
| Founded | 1990 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Shoe Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 2.6B |
| IPO Year | 1993 | 2020 |
Fundamental Metrics
Financial Performance| Metric | SHOO | OLMA |
|---|---|---|
| Price | $43.03 | $26.31 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 6 |
| Target Price | ★ $41.00 | $40.50 |
| AVG Volume (30 Days) | 960.3K | ★ 2.8M |
| Earning Date | 11-05-2025 | 11-10-2025 |
| Dividend Yield | ★ 1.95% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.78 | N/A |
| Revenue | ★ $2,362,727,000.00 | N/A |
| Revenue This Year | $13.10 | N/A |
| Revenue Next Year | $11.74 | N/A |
| P/E Ratio | $55.13 | ★ N/A |
| Revenue Growth | ★ 6.41 | N/A |
| 52 Week Low | $19.05 | $2.86 |
| 52 Week High | $44.99 | $36.26 |
Technical Indicators
Market Signals| Indicator | SHOO | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 56.66 | 49.19 |
| Support Level | $42.45 | $25.85 |
| Resistance Level | $43.90 | $36.26 |
| Average True Range (ATR) | 1.03 | 2.62 |
| MACD | -0.35 | -1.31 |
| Stochastic Oscillator | 22.27 | 0.85 |
Price Performance
Historical ComparisonAbout SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.